Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical-Grade Cannabis

被引:47
作者
Brunt, Tibor M. [1 ,2 ]
van Genugten, Marianne [3 ]
Honer-Snoeken, Kathrin [4 ]
van de Velde, Marco J. [4 ]
Niesink, Raymond J. M. [1 ]
机构
[1] Netherlands Inst Mental Hlth & Addict, NL-3500 VJ Utrecht, Netherlands
[2] Univ Amsterdam, Dept Psychiat, Amsterdam, Netherlands
[3] Univ Utrecht, Dept Pharm, Utrecht, Netherlands
[4] Minist Hlth, Off Med Cannabis, The Hague, Netherlands
关键词
medicinal cannabis; delta-9-tetrahydrocannabinol; cannabidiol; subjective effects; visual analog scale; DELTA(9)-TETRAHYDROCANNABINOL; MARIJUANA; CB1; PHARMACOLOGY; DISORDERS; VALIDITY; SMOKING; POTENCY; CANCER; MOOD;
D O I
10.1097/JCP.0000000000000129
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In The Netherlands, pharmaceutical-grade cultivated cannabis is distributed for medicinal purposes as commissioned by the Ministry of Health. Few studies have thus far described its therapeutic efficacy or subjective (adverse) effects in patients. The aims of this study are to assess the therapeutic satisfaction within a group of patients using prescribed pharmaceutical-grade cannabis and to compare the subjective effects among the available strains with special focus on their delta-9-tetrahydrocannabinol and cannabidiol content. In a cross-sectional and natural design, users of pharmaceutical-grade cannabis were investigated with questionnaires. Medical background of the patients was asked as well as experienced therapeutic effects and characteristics of cannabis use. Subjective effects were measured with psychometric scales and used to compare among the strains of cannabis used across this group of patients. One hundred two patients were included; their average age was 53 years and 76% used it for more than a year preceding this study. Chronic pain (53%; n = 54) was the most common medical indication for using cannabis followed by multiple sclerosis (23%; n = 23), and 86% (n = 88) of patients (almost) always experienced therapeutic satisfaction when using pharmaceutical cannabis. Dejection, anxiety, and appetite stimulation were found to differ among the 3 strains of cannabis. These results show that patients report therapeutic satisfaction with pharmaceutical cannabis, mainly pain alleviation. Some subjective effects were found to differ among the available strains of cannabis, which is discussed in relation to their different tetrahydrocannabinol/cannabidiol content. These results may aid in further research and critical appraisal for medicinally prescribed cannabis products.
引用
收藏
页码:344 / 349
页数:6
相关论文
共 47 条
[1]  
Aggarwal Sunil K, 2009, J Opioid Manag, V5, P257
[2]   Cannabinoids in medicine: A review of their therapeutic potential [J].
Amar, MB .
JOURNAL OF ETHNOPHARMACOLOGY, 2006, 105 (1-2) :1-25
[3]  
Arnold JC, 2012, CURR PHARM DESIGN, V18, P5113, DOI 10.2174/138161212802884726
[4]   The therapeutic potential of cannabis [J].
Baker, D ;
Pryce, G ;
Giovannoni, G ;
Thompson, AJ .
LANCET NEUROLOGY, 2003, 2 (05) :291-298
[5]   Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients [J].
Bergamaschi, Mateus M. ;
Costa Queiroz, Regina Helena ;
Nisihara Chagas, Marcos Hortes ;
Gomes de Oliveira, Danielle Chaves ;
De Martinis, Bruno Spinosa ;
Kapczinski, Flavio ;
Quevedo, Joao ;
Roesler, Rafael ;
Schroeder, Nadja ;
Nardi, Antonio E. ;
Martin-Santos, Rocio ;
Cecilio Hallak, Jaime Eduardo ;
Zuardi, Antonio Waldo ;
Crippa, Jose Alexandre S. .
NEUROPSYCHOPHARMACOLOGY, 2011, 36 (06) :1219-1226
[6]   Tetrahydrocannabinol and endocannabinoids in feeding and appetite [J].
Berry, EM ;
Mechoulam, R .
PHARMACOLOGY & THERAPEUTICS, 2002, 95 (02) :185-190
[7]   Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology [J].
Bhattacharyya, Sagnik ;
Morrison, Paul D. ;
Fusar-Poli, Paolo ;
Martin-Santos, Rocio ;
Borgwardt, Stefan ;
Winton-Brown, Toby ;
Nosarti, Chiara ;
O'Carroll, Colin M. ;
Seal, Marc ;
Allen, Paul ;
Mehta, Mitul A. ;
Stone, James M. ;
Tunstall, Nigel ;
Giampietro, Vincent ;
Kapur, Shitij ;
Murray, Robin M. ;
Zuardi, Antonio W. ;
Crippa, Jose A. ;
Atakan, Zerrin ;
McGuire, Philip K. .
NEUROPSYCHOPHARMACOLOGY, 2010, 35 (03) :764-774
[8]   Sedative, stimulant, and other subjective effects of marijuana: Relationships to smoking techniques [J].
Block, RI ;
Erwin, WJ ;
Farinpour, R ;
Braverman, K .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 59 (02) :405-412
[9]   Review of the validity and significance of cannabis withdrawal syndrome [J].
Budney, AJ ;
Hughes, JR ;
Moore, BA ;
Vandrey, R .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (11) :1967-1977
[10]   Cannabis and anxiety: a critical review of the evidence [J].
Crippa, Jose Alexandre ;
Zuardi, Antonio Waldo ;
Martin-Santos, Rocio ;
Bhattacharyya, Sagnik ;
Atakan, Zerrin ;
McGuire, Philip ;
Fusar-Poli, Paolo .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (07) :515-523